Search company, investor...
Lophius Biosciences company logo

Lophius Biosciences

Founded Year



Acquired | Acquired

Total Raised


About Lophius Biosciences

Lophius Biosciences is a privately-held biotech company focused on the development and marketing of T cell-based research tools, contract research solutions and diagnostics for functional assessment of pathogen/disease-reactive T cells. The company's flagship product is T-Track CMV, a diagnostic system intended to determine the functionality of the cell-mediated immune response in cytomegalovirus (CMV) seropositive transplant patients who undergo an immunosuppressive therapy. On March 9th, 2021, Lophius Biosciences was acquired by Mikrogen. The terms of the transaction were not disclosed.

Headquarters Location

Am BioPark 13

Regensburg, 93053,


+49 941 63091970

Missing: Lophius Biosciences's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Lophius Biosciences's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Lophius Biosciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Lophius Biosciences is included in 4 Expert Collections, including Regenerative Medicine.


Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).


Medical Devices

8,633 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.


Health IT

7,901 items

Lophius Biosciences Patents

Lophius Biosciences has filed 8 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Human proteins
  • Immune system
patents chart

Application Date

Grant Date


Related Topics




Immune system, Immunology, Clusters of differentiation, Transcription factors, Autoimmune diseases


Application Date


Grant Date



Related Topics

Immune system, Immunology, Clusters of differentiation, Transcription factors, Autoimmune diseases



Latest Lophius Biosciences News

Mikrogen Diagnostik erwirbt Lophius Biosciences

Mar 9, 2021

Mikrogen Diagnostik erwirbt Lophius Biosciences ) Das Diagnostikunternehmen Mikrogen GmbH aus Neuried erwirbt die Lophius Biosciences GmbH aus dem BioPark Regensburg, um in den Zukunftsmarkt für T-Zell-basierte Tests einzusteigen. Die Immundiagnostik spielt eine große Rolle in den Bereichen Transplantation sowie Infektions- und Autoimmunerkrankungen. Die 2002 aus der Universität Regensburg heraus gegründete Lophius Biosciences GmbH wurde von Mikrogen Diagnostik erworben. Seit 1989 produziert die Mikrogen GmbH im oberbayerischen Neuried mit 150 Mitarbeitern Antigene für die klinische Diagnostik. Der globale Anbieter von Systemlösungen für die medizinische Labordiagnostik bietet vielfältige serologische und molekulardiagnostische Systeme an. Der Schwerpunkt liegt auf der direkten und indirekten Detektion von bakteriellen, viralen und parasitären Infektionen sowie auf Autoimmun- und Krebserkrankungen. Die Kombination des Know-hows in Diagnostik und Automation von Mikrogen mit der Lophius Technologie zur pathogenspezifischen Immunstimulation, wird neuartige diagnostische Lösungen für Infektionskrankheiten ermöglichen und das Mikrogen-Portfolio ergänzen. Mikrogen wird den Betrieb erweitern, indem sie das gesamte Lophius-Team und die Lophius-Labore im BioPark Regensburg übernimmt. In Zukunft werden die von Lophius entwickelten In-vitro-Diagnosekits von Mikrogen vermarktet. „Wir freuen uns, unsere neuen Kollegen von Lophius an Bord begrüßen zu dürfen. Wir glauben, dass die Zusammenführung der beiden Teams und ihres komplementären Fachwissens unsere Innovationskraft bei der Entwicklung neuer diagnostischer Lösungen beschleunigen wird“, sagte Dr. Erwin Soutschek, CEO & Geschäftsführer der Mikrogen GmbH. Weitere Informationen unter: 11:00

Lophius Biosciences Frequently Asked Questions (FAQ)

  • When was Lophius Biosciences founded?

    Lophius Biosciences was founded in 2008.

  • Where is Lophius Biosciences's headquarters?

    Lophius Biosciences's headquarters is located at Am BioPark 13, Regensburg.

  • What is Lophius Biosciences's latest funding round?

    Lophius Biosciences's latest funding round is Acquired.

  • How much did Lophius Biosciences raise?

    Lophius Biosciences raised a total of $23.84M.

  • Who are the investors of Lophius Biosciences?

    Investors of Lophius Biosciences include Mikrogen, Bayern Kapital, VRD GmbH, Wolf Biotech, WIC GmbH and 8 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.